On the other hand, Cutaneous T-Cell Lymphoma (CTCL) and melanoma cells express a high level of SOCS-3, which protects malignant cells from cytokine-mediated antitumor effect, e.g., IFN-α [7, 14, 15]. Here, SOCS3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.